{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:33:27Z","timestamp":1792510407559,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018870","name":"Swedish Heart and Lung Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018870","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010234","name":"Astma och Allergif\u00f6rbundet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010234","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006706","name":"Tampereen Tuberkuloosis\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006706","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jaip.2025.07.009","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T16:08:11Z","timestamp":1752768491000},"page":"2970-2979.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Characteristics of Adult Asthma Based on Type 2 Inflammation Markers: A Population-Based Study"],"prefix":"10.1016","volume":"13","author":[{"given":"Selin","family":"Ercan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reshed","family":"Abohalaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinja","family":"Ilmarinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauri","family":"Lehtim\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saliha Selin Ozuygur","family":"Ermis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniil","family":"Lisik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muwada Bashir Awad","family":"Bashir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhika","family":"Jadhav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iida","family":"V\u00e4h\u00e4talo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"Malmh\u00e4ll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Backman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6ran","family":"Wennergren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Ekerljung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"L\u00f6tvall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teet","family":"Pullerits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"R\u00e5dinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bright I.","family":"Nwaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannu","family":"Kankaanranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2025.07.009_bib2","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0201-2022","article-title":"Phenotype overlap in the natural history of asthma","volume":"32","author":"Ricciardolo","year":"2023","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jaip.2025.07.009_bib3","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.jaip.2020.09.051","article-title":"The prevalence of subtypes of type 2 inflammation in an unselected population of patients with severe asthma","volume":"9","author":"Frossing","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.009_bib4","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00483-2022","article-title":"Distribution of type 2 biomarkers and association with severity, clinical characteristics and comorbidities in the BREATHE real-life asthma population","volume":"9","author":"Frossing","year":"2023","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jaip.2025.07.009_bib5","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.jaip.2019.11.006","article-title":"T2-\"low\" asthma: overview and management strategies","volume":"8","author":"Fitzpatrick","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.009_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11882-017-0686-1","article-title":"Mechanisms driving gender differences in asthma","volume":"17","author":"Fuseini","year":"2017","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2025.07.009_bib7","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0140-6736(22)02125-0","article-title":"Asthma","volume":"401","author":"Porsbjerg","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2025.07.009_bib8","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.3390\/biomedicines9111684","article-title":"Characterization of T2-low and T2-high asthma phenotypes in real-life","volume":"9","author":"Ricciardolo","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.jaip.2025.07.009_bib9","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.2147\/JIR.S295038","article-title":"Recent insights into the management of inflammation in asthma","volume":"14","author":"Rupani","year":"2021","journal-title":"J Inflamm Res"},{"key":"10.1016\/j.jaip.2025.07.009_bib10","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00528-2020","article-title":"Treatment options in type-2 low asthma","volume":"57","author":"Hinks","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.07.009_bib11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S2213-2600(20)30397-0","article-title":"Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial","volume":"9","author":"Heaney","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2025.07.009_bib12","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jaip.2024.01.023","article-title":"Phenotyping of severe asthma in the era of broad-acting anti-asthma biologics","volume":"12","author":"Bourdin","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.009_bib13","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3390\/biom13071118","article-title":"Type 2 low biomarker stability and exacerbations in severe uncontrolled asthma","volume":"13","author":"Viinanen","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.jaip.2025.07.009_bib14","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jaip.2023.12.021","article-title":"Burden of uncontrolled severe asthma with and without elevated type-2 inflammatory biomarkers","volume":"12","author":"Ding","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.009_bib15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1164\/rccm.202201-0129OC","article-title":"Exacerbation profile and risk factors in a type-2-low enriched severe asthma cohort: a clinical trial to assess asthma exacerbation phenotypes","volume":"206","author":"McDowell","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2025.07.009_bib16","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1016\/j.jaip.2023.05.028","article-title":"Comprehensive characterization of difficult-to-treat asthma reveals near absence of T2-low status","volume":"11","author":"Rupani","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.009_bib17","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jaip.2018.05.032","article-title":"Prevalence of patients eligible for anti-IL-5 treatment in a cohort of adult-onset asthma","volume":"7","author":"Ilmarinen","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.009_bib18","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.2147\/JAA.S327659","article-title":"Severe asthma in a general population study: prevalence and clinical characteristics","volume":"14","author":"Ronnebjerg","year":"2021","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.jaip.2025.07.009_bib19","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/cea.13378","article-title":"Severe asthma\u2014a population study perspective","volume":"49","author":"Backman","year":"2019","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2025.07.009_bib20","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-027808","article-title":"Cohort profile: the West Sweden Asthma Study (WSAS): a multidisciplinary population-based longitudinal study of asthma, allergy and respiratory conditions in adults","volume":"9","author":"Nwaru","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.jaip.2025.07.009_bib21","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1378\/chest.14-2457","article-title":"Biomarker profiles in asthma with high vs low airway reversibility and poor disease control","volume":"148","author":"Busse","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2025.07.009_bib22","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.07.009_bib23","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01209-2020","article-title":"Long-term prognosis of new adult-onset asthma in obese patients","volume":"57","author":"Ilmarinen","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.07.009_bib25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaci.2003.09.008","article-title":"Development of the asthma control test: a survey for assessing asthma control","volume":"113","author":"Nathan","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.009_bib26","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4104\/pcrj.2009.00010","article-title":"The Asthma Control Test (ACT) as a predictor of GINA guideline-defined asthma control: analysis of a multinational cross-sectional survey","volume":"18","author":"Thomas","year":"2009","journal-title":"Prim Care Respir J"},{"key":"10.1016\/j.jaip.2025.07.009_bib27","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.2147\/JAA.S430183","article-title":"How does mild asthma differ phenotypically from difficult-to-treat asthma?","volume":"16","author":"Naftel","year":"2023","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.jaip.2025.07.009_bib28","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jaip.2023.12.010","article-title":"Association of sputum eosinophilia with easily measured type-2 inflammatory biomarkers in untreated mild persistent asthma","volume":"12","author":"Covar","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.009_bib29","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.arbres.2023.07.026","article-title":"The role of inflammatory phenotype in patients with exacerbation-prone asthma and ongoing therapy","volume":"59","author":"Pilia","year":"2023","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.jaip.2025.07.009_bib30","first-page":"254","article-title":"Phenotype characterization and biomarker evaluation in moderate to severe type 2-high asthma","volume":"43","author":"Imoto","year":"2025","journal-title":"Asian Pac J Allergy Immunol"},{"key":"10.1016\/j.jaip.2025.07.009_bib31","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.jaip.2022.12.019","article-title":"A randomized trial of a composite T2-biomarker strategy adjusting corticosteroid treatment in severe asthma: a post hoc analysis by sex","volume":"11","author":"Eastwood","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.009_bib32","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.rmed.2019.06.003","article-title":"Age- and gender-specific incidence of new asthma diagnosis from childhood to late adulthood","volume":"154","author":"Honkamaki","year":"2019","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2025.07.009_bib33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jaip.2016.08.015","article-title":"Age-specific incidence of new asthma diagnoses in Finland","volume":"5","author":"Kankaanranta","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.07.009_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/clt2.70015","article-title":"Lifetime asthma incidence is related to age at onset and allergies in western Sweden","volume":"14","author":"Abohalaka","year":"2024","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2025.07.009_bib35","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/thoraxjnl-2020-215168","article-title":"Characterisation of patients with severe asthma in the UK Severe Asthma Registry in the biologic era","volume":"76","author":"Jackson","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2025.07.009_bib36","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00125-2017","article-title":"An algorithmic approach for the treatment of severe uncontrolled asthma","volume":"4","author":"Zervas","year":"2018","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jaip.2025.07.009_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.106924","article-title":"Reduced bronchodilator reversibility correlates with non-type 2 high asthma and future exacerbations: a prospective cohort study","volume":"200","author":"Liu","year":"2022","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2025.07.009_bib38","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02536-2017","article-title":"Associations between blood eosinophils and decline in lung function among adults with and without asthma","volume":"51","author":"Hancox","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.07.009_bib39","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1164\/rccm.202310-1751LE","article-title":"Biomarkers associated with lung function decline and dupilumab response in patients with asthma","volume":"209","author":"Pavord","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2025.07.009_bib40","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/thorax-2023-220972","article-title":"Type-2 inflammation and lung function decline in chronic airway disease in the general population","volume":"79","author":"Colak","year":"2024","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2025.07.009_bib41","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/thoraxjnl-2021-217325","article-title":"Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide","volume":"77","author":"Couillard","year":"2022","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2025.07.009_bib42","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S2213-2600(15)00367-7","article-title":"Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study","volume":"3","author":"Price","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2025.07.009_bib43","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jaci.2013.06.007","article-title":"Exhaled nitric oxide levels and blood eosinophil counts independently associate with wheeze and asthma events in National Health and Nutrition Examination Survey subjects","volume":"132","author":"Malinovschi","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.009_bib44","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S2213-2600(25)00037-2","article-title":"Inflammatory and clinical risk factors for asthma attacks (ORACLE2): a patient-level meta-analysis of control groups of 22 randomised trials","volume":"13","author":"Meulmeester","year":"2025","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2025.07.009_bib45","doi-asserted-by":"crossref","first-page":"133","DOI":"10.14740\/jocmr5162","article-title":"The determinants of eosinophilia in patients with severe asthma","volume":"16","author":"Abi Melhem","year":"2024","journal-title":"J Clin Med Res"},{"key":"10.1016\/j.jaip.2025.07.009_bib46","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02391-2024","article-title":"Phenotyping the responses to systemic corticosteroids in the management of asthma attacks (PRISMA)","volume":"65","author":"Celis-Preciado","year":"2025","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.07.009_bib47","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00570-2021","article-title":"Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype Oxford Asthma Attack Risk Scale (ORACLE)","volume":"8","author":"Couillard","year":"2022","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jaip.2025.07.009_bib48","article-title":"Burden of asthma by severity and exacerbation frequency among adult patients naive to biologic asthma therapy: a Finnish cohort study","volume":"4","author":"Kankaanranta","year":"2025","journal-title":"J Allergy Clin Immunol Glob"},{"key":"10.1016\/j.jaip.2025.07.009_bib49","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1465-9921-15-79","article-title":"Frequent cough in unsatisfactory controlled asthma\u2014results from the population-based West Sweden Asthma study","volume":"15","author":"Mincheva","year":"2014","journal-title":"Respir Res"},{"key":"10.1016\/j.jaip.2025.07.009_bib50","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jaci.2003.09.008","article-title":"Development of the asthma control test: a survey for assessing asthma control","volume":"113","author":"Nathan","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.07.009_bib51","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4104\/pcrj.2009.00010","article-title":"The Asthma Control Test (ACT) as a predictor of GINA guideline-defined asthma control: analysis of a multinational cross-sectional survey","volume":"18","author":"Thomas","year":"2009","journal-title":"Prim Care Respir J"},{"key":"10.1016\/j.jaip.2025.07.009_bib53","first-page":"1","article-title":"Epidemiology standardization project (American Thoracic Society)","volume":"118","author":"Ferris","year":"1978","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaip.2025.07.009_bib54","first-page":"952","article-title":"Surveillance for respiratory hazards in the occupational setting [American Thoracic Society]","volume":"126","year":"1982","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaip.2025.07.009_bib56","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1164\/rccm.201908-1590ST","article-title":"Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society Technical Statement","volume":"200","author":"Graham","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2025.07.009_bib57","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.07.009_bib58","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00016-2016","article-title":"2017 ERS\/ATS standards for single-breath carbon monoxide uptake in the lung","volume":"49","author":"Graham","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.07.009_bib59","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2045-7022-3-3","article-title":"The skin prick test\u2014European standards","volume":"3","author":"Heinzerling","year":"2013","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2025.07.009_bib60","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1164\/rccm.200406-710ST","article-title":"ATS\/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005","volume":"171","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2025.07.009_bib61","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00965-2016","article-title":"A European Respiratory Society technical standard: exhaled biomarkers in lung disease","volume":"49","author":"Horvath","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.07.009_bib62","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1183\/09031936.00202013","article-title":"International ERS\/ATS guidelines on definition, evaluation and treatment of severe asthma","volume":"43","author":"Chung","year":"2014","journal-title":"Eur Respir J"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825006427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825006427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T12:08:40Z","timestamp":1774958920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219825006427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":58,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2213219825006427"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2025.07.009","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics of Adult Asthma Based on Type 2 Inflammation Markers: A Population-Based Study","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2025.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}